(FENC) –
-
Form 4 FENNEC PHARMACEUTICALS For: Apr 19 Filed by: Haigh Adrian
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Haigh Adrian
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Haigh Adrian
-
Form 4 FENNEC PHARMACEUTICALS For: Apr 17 Filed by: Haigh Adrian
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Haigh Adrian
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Haigh Adrian
-
Form 4 FENNEC PHARMACEUTICALS For: Apr 15 Filed by: Haigh Adrian
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Haigh Adrian
-
Form 4 FENNEC PHARMACEUTICALS For: Apr 15 Filed by: RALLIS CHRIS A
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Haigh Adrian
-
Form 4 FENNEC PHARMACEUTICALS For: Apr 04 Filed by: Raykov Rosty
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty
-
Fennec Pharmaceuticals Inc. (FENC) PT Raised to $18 at H.C. Wainwright
-
Form 4 FENNEC PHARMACEUTICALS For: Apr 03 Filed by: Raykov Rosty
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty
-
Form 4 FENNEC PHARMACEUTICALS For: Apr 01 Filed by: Andrade Robert
-
Form 4 FENNEC PHARMACEUTICALS For: Apr 01 Filed by: Raykov Rosty
-
Form 10-K FENNEC PHARMACEUTICALS For: Dec 31
-
Form 4 FENNEC PHARMACEUTICALS For: Mar 26 Filed by: RALLIS CHRIS A
-
Form 4 FENNEC PHARMACEUTICALS For: Mar 26 Filed by: Andrade Robert
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Andrade Robert
-
Form 4 FENNEC PHARMACEUTICALS For: Mar 25 Filed by: Andrade Robert
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Andrade Robert
-
Form 8-K FENNEC PHARMACEUTICALS For: Mar 21
-
Fennec Pharmaceuticals Inc. (FENC) PT Raised to $20 at Craig-Hallum
-
Form 8-K FENNEC PHARMACEUTICALS For: Mar 15
-
Fennec Pharmaceuticals (FENC) Misses Q4 EPS by 10c
-
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
-
Fennec Pharmaceuticals Inc. (FENC) PT Raised to $18 at Craig-Hallum
-
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
-
Fennec Pharmaceuticals (FENC) and Norgine Enter into Exclusive Licensing Agreement
-
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
-
Form 424B7 FENNEC PHARMACEUTICALS
-
Form 8-K/A FENNEC PHARMACEUTICALS For: Feb 29
-
Form 8-K FENNEC PHARMACEUTICALS For: Feb 29
-
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
-
Form SC 13G FENNEC PHARMACEUTICALS Filed by: Solas Capital Management, LLC
-
Form 8-K FENNEC PHARMACEUTICALS For: Feb 01
-
Fennec Pharmaceuticals (FENC) Reports FDA Issued Reminder of Non-Substitution of PEDMARK for Pediatric Patients Receiving Cisplatin
-
FDA Issues Reminder of Non-Substitution of PEDMARKĀ® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
-
Form 4 FENNEC PHARMACEUTICALS For: Jan 04 Filed by: Andrade Robert
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Andrade Robert
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Andrade Robert
-
Form 4 FENNEC PHARMACEUTICALS For: Dec 28 Filed by: Raykov Rosty
-
Form 4 FENNEC PHARMACEUTICALS For: Dec 26 Filed by: RALLIS CHRIS A
-
Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty
-
Form EFFECT FENNEC PHARMACEUTICALS
-
Form 8-K FENNEC PHARMACEUTICALS For: Dec 04
-
Fennec Announces Incremental $5 Million Investment from Petrichor
Back to FENC Stock Lookup